Jerusalem-based developer of novel diagnostic and therapeutic solutions including diagnostic kits for a variety of diseases with current focus on the early detection of Graft-versus-Host-Disease (GVHD). The diagnostic kit for GVHD provides a faster, less expensive, and more reliable tool than anything currently on the market. Seeking introductions to pharma companies with distribution, partners for clinical trials, and investment.
